Dr. Luke Fischer (he/his) is a neurologist-neuroscientist with an interest in Lewy body disease. He graduated Phi Beta Kappa from Michigan State University with degrees in Philosophy and Biochemistry & Molecular Biology, and he remained there to complete his PhD degree in Neuroscience in the laboratory of Dr. Caryl E. Sortwell as part of a dual-MD/PhD program. As a trainee in the NINDS Morris K. Udall Center of Excellence for Parkinson's Disease Research at Michigan State University, his focus was on the use of deep brain stimulation in rodent models of Parkinson's disease to investigate its potential as a neuroprotective therapy. He remained in her laboratory as a postdoctoral fellow to examine the impact of common genetic variants on clinical outcomes for developing precision medicine approaches for treating patients with Parkinson's disease. He completed his neurology residency at the University of Alabama at Birmingham where he was elected to AOA and served as Chief Resident. As a NINDS R25 resident trainee in the laboratory of Dr. Laura Volpicelli-Daley, he applied confocal and expansion microscopy techniques to human postmortem brain samples to examine co-pathology. Dr. Fischer completed his clinical fellowship in Behavioral Neurology at the University of California, San Francisco Memory and Aging Center and remained there for his NINDS UE5 research fellowship in the laboratory of Dr. Lea Grinberg.
Publications
Sex Differences in Associations of Lewy Body Disease with Alzheimer's Disease and Cognitive Decline.
